Berobenatide
unknown (auto-discovered: incretin-obesity)
Also known as: MET097, PF-08653944
Classification
Peptide
Regulatory Status
investigational; registered trials: NCT07881757, NCT07874633, NCT07876531 (PHASE3/PHASE1)
Unofficial source
Sources
4
Review
pending review
Overview
Unknown — Berobenatide was found by open discovery on 2026-10-26 and has not been researched yet.
Evidence and limitations
Known
n/a
Unknown
- Mechanism, dosing, safety, interactions and efficacy are unknown until research runs on this auto-discovered draft.
Study details: trial conditions, not guidance
These are the conditions researchers used in a controlled trial with medical supervision. They aren't instructions.
Doses found
Doses as found in each source, with its grade. What was found, not a direction.
Studies, trials and professional sources
n/a
Reddit, Facebook, Instagram, forums and blogs
n/a
Claims and grades
- Not gradedBerobenatide is being studied in a registered trial: A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Do Not Use a Breathing Machine (PAP) (VESPER-OSA 2) (NCT07881757; PHASE3; NOT_YET_RECRUITING; sponsor Pfizer; intervention "Berobenatide" (DRUG)).
- Not gradedBerobenatide is being studied in a registered trial: A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or Obesity (NCT07874633; PHASE3; NOT_YET_RECRUITING; sponsor Pfizer; intervention "Berobenatide" (DRUG)).
- Not gradedBerobenatide is being studied in a registered trial: A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken up Into the Blood in Adults With Overweight or Obesity (NCT07876531; PHASE1; NOT_YET_RECRUITING; sponsor Pfizer; intervention "Berobenatide" (DRUG)).
- Not gradedBerobenatide is being studied in a registered trial: A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity (NCT07845500; PHASE3; RECRUITING; sponsor Pfizer; intervention "Berobenatide" (DRUG)).
Sources (4)
- A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Do Not Use a Breathing Machine (PAP) (VESPER-OSA 2) (opens in a new tab) · ClinicalTrials.gov · trial-registry · 2026-10-19
- A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or Obesity (opens in a new tab) · ClinicalTrials.gov · trial-registry · 2026-10-15
- A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken up Into the Blood in Adults With Overweight or Obesity (opens in a new tab) · ClinicalTrials.gov · trial-registry · 2026-10-15
- A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity (opens in a new tab) · ClinicalTrials.gov · trial-registry · 2026-09-29
Educational reference only — not medical advice.
What people report (anecdote)
CLINICAL DATA (from trials)
Adverse events:
None recorded in our sources.
Effects measured:
Human trials: none found.
ANECDOTE
What people report: anecdote, not evidence
Loading…
Submit a claim you saw